Abstract
Drug discovery is usually a rule-based process that is carefully carried out by pharmacists. However, a new trend is emerging in research and practice where artificial intelligence is being used for drug discovery to increase efficiency or to develop new drugs for previously untreatable diseases. Nevertheless, so far, no study takes a holistic view of AI-based drug discovery research. Given the importance and potential of AI for drug discovery, this lack of research is surprising. This study aimed to close this research gap by conducting a bibliometric analysis to identify all relevant studies and to analyze interrelationships among algorithms, institutions, countries, and funding sponsors. For this purpose, a sample of 3884 articles was examined bibliometrically, including studies from 1991 to 2022. We utilized various qualitative and quantitative methods, such as performance analysis, science mapping, and thematic analysis. Based on these findings, we furthermore developed a research agenda that aims to serve as a foundation for future researchers.
Subject
Drug Discovery,Pharmaceutical Science,Molecular Medicine
Reference128 articles.
1. Poduri, R. (2021). Drug Discovery and Development, Springer.
2. Roser, M., Ortiz-Ospina, E., and Ritchie, H. (2022, October 29). Life Expectancy. Available online: https://ourworldindata.org/life-expectancy.
3. Zanders, E.D. (2020). The Science and Business of Drug Discovery: Demystifying the Jargon, Springer. [2nd ed.].
4. Jumping into the 20th century before it is too late: Is laboratory robotics still in its infancy?;Weinstein;J. Automat. Chem.,1992
5. Successful implementation of automation in medicinal chemistry;Coates;Drug Discov. Today,2000
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献